PET157 Mobility

Presentation information

Listed presentation sizes are 5 mg / 2 mL, 10 mg / 2 mL and 15 mg / 2 mL. They describe the research presentation; they are not animal-size recommendations or administration instructions.

Ask for the exact ingredient identity, amount of each component, batch and supporting documentation before any professional assessment. The combined total alone does not establish the amount of each ingredient.

Australian availability

Availability, the responsible supplier and any applicable veterinary pathway must be confirmed for Australia before a supply quotation. We do not advertise an active treatment or prescribing service.

Any later quotation must state the currency, final amount, dispatch origin, delivery conditions and applicable import requirements. Historical USD package prices are not an Australian offer.

Certificate of analysis (COA)

Start with a product enquiry identifying the concept, presentation and batch. Ask which documents exist and what registration or access steps apply before sharing any additional information. COA documentation is available after registration where applicable. An analytical result describes the tested sample; it does not establish clinical effectiveness.

Research and limitations

Mobility, connective-tissue and recovery research remains a professional-review concept. Controlled canine combination trials have not established clinical efficacy.

Read the compound and formulation evidence separately from product availability. Your veterinarian remains responsible for individual care decisions.